Who are AnaptysBio, Inc.'s main suppliers?

AnaptysBio, Inc. (ANAB) key suppliers include: FIRST-TRACKS-BIOTHERAPEUTICS. View the full supplier network at chainsifter.com/chain/ANAB.

Who are AnaptysBio, Inc.'s major customers?

AnaptysBio, Inc. (ANAB) key customers include: UK-LIMITED. View the full customer network at chainsifter.com/chain/ANAB.

What sector is AnaptysBio, Inc. in?

AnaptysBio, Inc. (ANAB) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

ANAB Supply Chain: AnaptysBio, Inc. Suppliers & Customers

1Suppliers

1Customers

3Debt Items

8Related Chains

AnaptysBio, Inc. Suppliers

Ticker	Name	Confidence	Evidence
FIRST-TRACKS-BIOTHERAPEUTICS	FIRST-TRACKS-BIOTHERAPEUTICS	92%	Effective as of the date of the distribution, First Tracks Biotherapeutics, on behalf of itself, grants to AnaptysBio a worldwide, perpetual, irrevocable, fully paid-up, royalty-free, non-transferabl…

AnaptysBio, Inc. Customers

Ticker	Name	Confidence	Evidence
UK-LIMITED	UK-LIMITED	85%	n and Distribution Agreement provides that any and all rights to receive milestone payments under the Vanda License Agreement will be allocated to First Tracks Biotherapeutics. Centessa On November 2…

AnaptysBio, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
ANAB-DEBT-7756	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2017-12-31.
ANAB-DEBT	Debt stack $277.4M	90%	Market cache reports total debt of $277.4M.
ANAB-DEBT-7755	Warrants outstanding: 287	90%	xbrl warrant detail from xbrl 2020-12-31.

AnaptysBio, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for AnaptysBio, Inc..

AnaptysBio, Inc. Ownership

Holder	Name	Confidence	Evidence
ANAB-OWNER-ECOR1-CAPITAL-LLC	EcoR1 Capital, LLC	90%	13F overlay lists EcoR1 Capital, LLC as top holder; 206 tracked holders.

AnaptysBio, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
LLY	Eli Lilly and Company	100.00	2
TGTX	TG Therapeutics, Inc.	50.00	2
BMY	Bristol-Myers Squibb Company	50.00	2
TRAX	First Tracks Biotherapeutics, Inc.	38.88	1	['receiving']
VNDA	Vanda Pharmaceuticals Inc.	38.88	1	['receiving']
SNYNF	Sanofi	14.78	2
JNJ	Johnson & Johnson	14.78	2
MRK	Merck & Co., Inc.	14.78	2

AnaptysBio, Inc. Supply Chain